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events in children and young adolescents. The spectrum of 
reactive lymph node changes is large, with differences pos-
sibly determined by regional variations in geography, demo-
graphics, catchment areas, seasons, and years, respectively. 
 © 2016 S. Karger AG, Basel 
 Introduction 
 As with many cancers, lymphomagenesis has been rec-
ognized as a multistep process with the acquisition of a 
range of oncogenic events usually requiring many years 
or decades to evolve. More recently, early lesions in lym-
phomagenesis have been described, including in particu-
lar certain variants of follicular lymphoma such as in situ 
follicular neoplasia (ISFN)  [1] , previously known as fol-
licular lymphoma in situ  [2] , in which the nodal architec-
ture is preserved and the lesion can by definition only be 
detected by immunohistochemistry (IHC), partial in-
volvement by follicular lymphoma, and duodenal follicu-
lar lymphoma, as well as in situ mantle cell neoplasia 
(ISMCN), previously known as in situ mantle cell lym-
phoma  [3–6] .
 The t(14; 18)(q32;q21) translocation, which results 
from erroneous  VDJ recombination, is one of the earliest 
events in follicular lymphomagenesis, occurring in B-cell 
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 Abstract 
 Objectives: While the incidence and prevalence of in situ
follicular neoplasia (ISFN) and in situ mantle cell neoplasia 
(ISMCN) in adults are well documented, little is known about 
these early (precursor) lesions in pediatric populations. The 
aim of this study was to analyze so-called ‘reactive’ lymph 
nodes harvested for the purpose of staging solid tumors, un-
explained lymphadenopathies, or presumed inflammatory 
processes or in conjunction with other surgical interventions 
in children and adolescents aged <18 years, with special at-
tention to ISFN and ISMCN.  Methods: Formalin-fixed, paraf-
fin-embedded reactive lymph node samples from an un-
selected pediatric population from two catchment areas in 
Switzerland were retrospectively analyzed for the presence 
of ISFN and ISMCN and specific reactive lymph node patterns. 
 Results: While a diverse range of histopathological patterns 
of reactive lymph node changes with a particular periodic in-
crease in mycobacterioses could be observed in this pediatric 
population, not a single case of ISFN or ISMCN  was found. 
 Conclusions: Early histological lymphomagenesis equiva-
lents in the form of in situ lymphomas are exceedingly rare 
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precursors in the bone marrow  [7] . Of note, this has also 
been observed in very low frequencies in circulating B 
cells from healthy adults  [8, 9] , increasing in frequency in 
older individuals  [10] . This genetic aberration, which is 
found in the vast majority of follicular lymphomas  [11] , 
leads to constitutive pathologic overexpression of the an-
ti-apoptotic bcl-2 protein in germinal center B cells  [12] , 
readily detectable in tissue sections by IHC.
 Similar to ISFN, the nodal architecture in ISMCN is 
preserved and can only be recognized by IHC detecting 
cyclin D1 expression on B cells in the mantle zones  [5, 6] . 
These ISMCN carry the characteristic t(11; 14) transloca-
tion observed in full-blown mantle cell lymphoma  [13] . 
Furthermore, cells carrying the t(11; 14) translocation can 
also be detected in the peripheral blood of healthy indi-
viduals, albeit at a very low frequency  [14] . In ISFN as well 
as in ISMCN, detection of transformed B cells within 
morphologically intact follicles may represent the tissue 
counterpart of transformed/translocation-carrying lym-
phocytes in the circulation.
 The incidence and prevalence of ISFN in the adult 
population have been described and they appear to be low 
 [15–17] . Similarly, ISMCN is an exceptionally rare event, 
as described by Adam et al.  [18] . Although it is to be ex-
pected that ISFN and ISMCN are a very rare event in the 
pediatric population, this has not been studied system-
atically before. The primary aim of this study therefore 
was to examine the frequency of nodal in situ neoplasms 
of the ISFN type, as well as ISMCN, in an unselected pe-
diatric population by retrospective analysis of surgical 
lymph node specimens. In light of the detailed reviews 
necessary to rule out (incidental) in situ neoplasms, the 
secondary aim was to more closely categorize the reactive 
lymph node changes observed.
 Materials and Methods 
 Case Selection 
 Cases for retrospective analysis were selected from pediatric 
patients with lymphadenectomy specimens from the Institutes of 
Pathology of the University of Bern and the University Hospital of 
Basel between 1990 and 2013. A search was conducted in both in-
stitutes using the software PathoWin+ (Basys Data, Binningen, 
Switzerland) with the terms ‘lymphadenectomy’/‘lymph node’. 
Lymph nodes had been removed for the purpose of staging solid 
tumors, unexplained lymphadenopathies or lymph node enlarge-
ment, or presumed inflammatory processes, or in conjunction 
with other surgical interventions (e.g. appendectomy). This study 
was approved by the ethics committee.
 Formalin-fixed, paraffin-embedded samples were available 
from all patients. Inclusion criteria included: absence of overt lym-
phoma in the examined lymph nodes, a negative clinical history of 
lymphoma, and presence of at least one reactive follicle with a rec-
ognizable germinal center in the routine hematoxylin and eosin 
(H&E)-stained sections. All patients were 18 years or younger at 
the time of lymph node excision. The main primary exclusion cri-
teria were: age >18 years, a history of lymphoma, and poor mate-
rial quality or quantity (inadequate initial resection material or 
insufficient remaining tissue volume or tissue preservation). A to-
tal of 392 patients (234 males and 158 females, median age 9.0 
years, range 0.2–18 years) were identified and amenable for anal-
ysis.
 Immunohistochemistry 
 All lymph nodes had been stained for routine histological ex-
amination with H&E. Those slides were used for double-headed 
review of the diagnoses (Y.B. and A.T. or S.H. and A.T.). All cases 
were stained for bcl-2 as well as for cyclin D1 by IHC on an auto-
mated immunostainer (Leica BOND-III, Leica Biosystems, Nuss-
loch, Germany, in Bern or BenchMark XT, Ventana Medical Sys-
tems, Tucson, Ariz., USA, in Basel). Following pretreatment ac-
cording to the manufacturer’s protocols, the slides were incubated 
at room temperature with monoclonal mouse anti-human bcl-2 
(working concentration 1: 100; Dako, Agilent Technologies, Glos-
trup, Denmark) and cyclin D1 (working concentration 1: 25; Cell 
Marque, Rocklin, Calif., USA). Antigen detection was performed 
using a commercial detection kit (Bond Polymer Refine Detection, 
UltraView Detection Kit; Ventana) with diaminobenzidin as the 
chromogen.
 Analysis of H&E Sections and IHC Staining 
 All H&E sections were reviewed by at least 2 board certified 
pathologists and assessed for suitability (see above). A morpho-
logical pattern diagnosis was made according to the following cat-
egories: follicular hyperplasia, paracortical hyperplasia, sinus his-
tiocytosis, necrotizing and nonnecrotizing granulomatous lymph-
adenitis, suppurative lymphadenitis, and (other, nonspecific) 
reactive changes. One to 4 histological diagnoses were made in 
each individual case. For assessment of the expression profile of 
bcl-2 and cyclin D1, the stained slides were evaluated by experi-
enced hematopathologists and ambiguous cases discussed.
 The diagnostic criteria for ISFN have previously been described 
 [4, 18] . They encompass lymph nodes with an intact lymphoid ar-
chitecture, including the presence of preserved paracortical/inter-
follicular areas and follicles with intact mantle zones. bcl-2-posi-
tive neoplastic cells of mainly the centrocytic type are confined to 
the germinal centers of the follicles, which show a low proliferative 
index. This definition aims to separate ISFN from partial involve-
ment by follicular lymphoma, in which an altered architecture 
with larger, often grouped affected follicles is observed with ill-
defined mantle cuffs, the presence of centroblasts, and a variable 
intensity of bcl-2 staining. Similar to ISFN, the nodal architecture 
in ISMCN is preserved, and as such it can also be recognized by 
IHC staining as the presence of cyclin D1-expressing cells within 
the mantle zone of otherwise reactive follicles  [5, 6] .
 Statistical Analysis 
 Results between groups were compared using a one-way-anal-
ysis of variance (ANOVA). p < 0.05 was considered statistically 
significant. Analyses were conducted using SAS v9.2 (SAS Insti-
tute, Cary, N.C., USA).
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 Results 
 Demographics 
 The clinicopathological characteristics of the two co-
horts are summarized in  table 1 . In total, 392 cases were 
amenable to analysis. Three hundred fifteen cases were 
from Bern [i.e. 194 (62%) males and 121 (38%) females] 
and 77 cases were from Basel [i.e. 40 (52%) males and 37 
(48%) females]. The Bern cohort presented with an aver-
age age of 9.6 ± 5.8 years (median 9.0 years, range 0.2–18 
years), and no significant sex-specific differences were 
noted (male average 9.5 ± 5.8 years, median 9.0 years, vs. 
female average 9.8 ± 5.8 years, median 10.0 years; p = 
0.321). The Basel cohort presented with an average age of 
9.1 ± 5.3 years (median 8.0 years, range 0.25–18 years), 
and no significant sex-specific differences were noted 
(male average 9.9 ± 5.3 years, median 9.5 years, vs. female 
average 8.3 ± 5.0 years, median 7.0 years; p = 0.092).
 Results of the Morphological Analysis 
 Figure 1 summarizes the distribution of the histopath-
ological diagnoses of the lymph node specimens. In total, 
536 diagnoses were rendered to the 392 reviewed cases. 
The most frequent reactive change observed was follicular 
hyperplasia (n = 248; 46.3%), followed by paracortical hy-
perplasia (n = 106; 19.8%) and sinus histiocytosis (n = 57; 
10.6%). Granulomatous lymphadenitis, with or without 
necrosis, constituted 9.2% (n = 49) of all of the diagnoses 
in the entire group, being particularly strongly represent-
ed in the Basel cohort, where this diagnosis constituted 
21.2% of all diagnoses. No sex predilection or annual or 
seasonal peak was observed. While in most cases a de-
scriptive diagnosis based on the morphological presenta-
tion was made, some lymphonodectomy specimens yield-
ed a definite diagnosis, in particular also after additional 
analyses (including molecular pathology; see  table 2 ).
 Results of IHC Staining 
 In all tissue sections of the entire cohort examined by 
conventional histology and IHC, not a single case of ISFN 
or ISMCN was detected. Clinical follow-up, where avail-
able, revealed development of lymphoma in 1 case from 
Basel with a diagnosis of nodular lymphocyte-predomi-
nant Hodgkin lymphoma 1 year after the initial lymph 
node excision in a 15-year-old boy. In 2 cases from Bern, 
EBV-associated lymphomas (diffuse large B-cell and 
Hodgkin’s lymphoma, classical type) were diagnosed in 2 
brothers aged 5 and 16 years (data last reviewed at the end 
of 2015).
 Table 1.  General characteristics of the pediatric cohorts from Bern 
and Basel
Bern
cohort
Basel
cohort
Total p value
Sex, n (%) n.s.
Male 194 (61.6) 40 (51.9) 234 (59.7)
Female 121 (38.4) 37 (48.1) 158 (40.3)
Age, years
Total n.s.
Mean ± SD 9.6 ± 5.8 9.1 ± 5.3 9.5 ± 5.7
Median 9.0 8.0 9.0
Range 0.2 – 18 0.25 – 18 0.2 – 18
Male n.s.
Mean ± SD 9.8 ± 5.8 9.9 ± 5.3 9.5 ± 5.7
Median 9.0 9.5 10.0
Range 0.25 – 18
Female n.s.
Mean ± SD 9.8 ± 5.8 8.3 ± 5.0 9.5 ± 5.7
Median 10.0 7.0 9.0 
Range 1.1 – 18
n.s. = Not significant.
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 Fig. 1. Distribution of the diagnoses from the Basel cohort (light 
grey) and the Bern cohort (dark grey) as percentages of the total 
diagnoses made in the surgical lymphonodectomy specimens.
FH = Follicular hyperplasia; PH = paracortical hyperplasia; GR = 
granulomatous lymphadenitis; GRN = granulomatous lymphad-
enitis with necrosis; SH = sinus histiocytosis; RA = reticulohistio-
cytic lymphadenitis with abscess; AB = frank abscess; RE = reactive 
(not otherwise categorized, including Kikuchi lymphadenitis, Ro-
sai-Dorfman lymphadenits, lymphangiectasia and fibrosis). 
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 Discussion 
 While the frequency of (incidental) ISFN and ISMCN 
in adults has been described  [15–18] , and its prevalence 
in the pediatric population is indeed expected to be even 
lower, no systematic study exists to prove the point of the 
true prevalence of (incidental) early nodal neoplasms, 
comprising ISFN and ISMCN, in an unselected pediatric 
population and to describe the morphological patterns of 
the reactive changes observed.
 In this large pediatric population (1990–2013), not a 
single case of ISFN or ISMCN lymphoma was detected.
 In previous studies of adult populations, the preva-
lence of ISFN has been shown to be in the low percent-
ages  [15–17] , whereas the prevalence of the signature 
t(14; 18) translocation in the peripheral blood of healthy 
individuals is comparatively high, increasing with age  [8–
10, 19] . While cord blood samples and peripheral blood 
mononuclear cells from children aged <10 years did not 
show any positive cells using quantitative real-time poly-
merase chain reaction  [16] , this increased to 66% of indi-
viduals in their 5th decade. Compared to ISFN, the prev-
alence of ISMCN in the adult population is even lower 
 [18] . The prevalence and incidence of follicular lympho-
ma and particularly mantle cell lymphoma in the pediat-
ric population are much lower compared to values in 
adults  [20] . As current evidence suggests that ISFN and 
ISMCN are early lesions in lymphomagenesis, preceding 
the occurrence of full-blown lymphoma by years if not 
decades, it is expected, but has to date not been proven in 
a large study, that such lesions will occur with a much 
lower frequency in a pediatric population. Indeed, ISFN 
and ISMCN were not detected in this large unselected pe-
diatric population. The probability of the appearance of 
the t(14; 18) translocation, which, on the whole, appears 
to be the only chromosomal imbalance (detectable by ar-
ray CGH) in follicular lymphoma in situ  [21] , is likely to 
increase with time and adequately explains the lack of 
ISFN detected in this young age group. Furthermore, al-
though smoking and exposure to pesticides cannot be en-
tirely excluded, the factors predisposing to increased lev-
els of circulating t(14; 18) cells  [21–23] are unlikely to 
have been significantly present in this study population.
 Of note, this study did not specifically look at potential 
precursor lesions for the now clearly recognized pediatric 
type follicular lymphoma, an indolent type of follicular 
lymphoma mainly affecting children and young adults, 
notably lacking the classical t(14; 18) translocation and 
bcl-2 protein expression  [24] .
 In addition to providing insight into the presence – or 
in this case the absence – of in situ lymphocytic neoplasias 
in a pediatric population, our study also provides inter-
esting information on the distribution of reactive lymph 
node changes in lymphadenectomy specimens. The spec-
trum of reactive lymph node changes was broad, with het-
erogeneous distributions possibly determined by region-
al variations in geography, demographics, catchment 
area, season, and year, respectively. As such, in pediatric 
lymph node samples lacking overt infiltration by malig-
nant lymphoma, the results of the current study support 
the necessity for a detailed workup to exclude treatable 
infectious or inflammatory alterations responsible for the 
observed reactive changes and to ‘exempt’ the pathologist 
from undertaking extensive studies to exclude the unlike-
ly event of ISFN or ISMCN. Interestingly, in a longer fol-
low-up, 1 patient was diagnosed with DiGeorge syn-
drome and 4 with autoimmune lymphoproliferative syn-
drome, 2 siblings of whom developed B-cell lymphopro-
liferations during the course of the follow-up. Also in 
these select cases, however, no early in situ lesions were 
observed.
 Study Limitations 
 Although the children undergoing lymphadenectomy, 
per definition, do not constitute an entirely ‘healthy’ pop-
ulation as such, there is no reason to believe that they dif-
fer significantly in their risk of presenting with ISFN or 
ISMCN compared to a truly healthy pediatric cohort. 
Furthermore, although extensive follow-up was not rou-
tinely available, only 3 cases presented with a malignant 
(non-mantle cell lymphoma and non-follicular lympho-
ma) lymphoma over time.
 Table 2.  Distribution of infectious and immune-dysregulatory 
lymphadenopathies
Diagnosis Basel/Bern (total)
Atypical mycobacteriosis 1/1 (2)
Mycobacterium avium LA 2/1 (3)
Mycobacterium tuberculosis LA 3/2 (5)
Bartonella henselae (cat scratch) LA 1/5 (6)
Rosai-Dorfman LA 1/0 (1)
Retrovirus-associated LA1 3/0 (3)
Immune-dysregulatory LA2 2/3 (5)
 1 One confirmed HIV+ case and 2 cases highly suspicious for 
HIV based on the morphological presentation but without conclu-
sive follow-up data. 2 One case of DiGeorge syndrome (Basel) and 
4 presumed cases of autoimmune lymphoproliferative syndrome 
(1 in Basel and 3 in Bern). LA = Lymphadenopathy.
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 In summary, in situ neoplasia of the ISFN and ISMCN 
type before the age of 18 years is an exceedingly rare and 
likely clinically insignificant finding. So, while this study 
provides an expected ‘negative result’, proof of this is of 
imminent importance as it provides first-hand evidence 
for the hypothesis of stepwise lymphomagenesis with 
age. Importantly, our data suggests that ancillary studies 
in addition to routine stains are not warranted to spe-
cifically search for and rule out ISFN or ISMCN. Clini-
cally relevant nonneoplastic lymph node changes, in par-
ticular those of an infectious or immune-dysregulatory 
nature, are much more important to recognize to poten-
tially guide clinical management and determine the fu-
ture follow-up of pediatric patients with lymphadenopa-
thies.
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